Andrew W.
About Andrew W.
Andrew W. is the Associate Director of Business Insights and Analytics at Bristol Myers Squibb, with extensive experience in various therapeutic areas and a successful track record in product launches and marketing initiatives.
Title
Andrew W. is currently the Associate Director of Business Insights and Analytics. He also serves as a District Business Manager for Immunology at Bristol Myers Squibb in the New York City Metropolitan Area.
Experience in Therapeutic Areas
Andrew W. has a diverse therapeutic experience spanning multiple critical areas such as oncology, cardiology, neurology, rheumatology, pulmonology, and pain management. His broad expertise enhances his capability to manage and optimize business strategies in various medical fields.
Successful Lung Cancer Therapy Launches
In 2018, Andrew W. successfully launched two Pfizer lung cancer therapies—Lorbrena and Vizimpro—into the competitive US market. His efforts resulted in early success indicators, including positive field accolades for seamless implementation and early uptake.
Marketing Initiatives in Breast Cancer
Andrew W. led key marketing initiatives across various breast cancer stakeholders, which significantly contributed to the Brand (Ibrance) performance, achieving 105% of the $2.8 billion budget in 2017, marking a 39% growth.
Field Launches for Pfizer Revenue Drivers
Andrew W. led two field launches for major Pfizer revenue drivers, Chantix and Eliquis. His leadership resulted in early uptake and sustained market share during the launch years.
Managing Agency Relationships and Budgets
Throughout his career, Andrew W. has successfully managed various agency relationships and optimized brand budgets ranging from $2 million to $132 million, demonstrating his strong capability in financial oversight and partnership management.
Leadership in Sales Attainment
Andrew W. successfully led the Boston District to a 2020 attainment of 118.54% over goal, placing the district in the Top 15%. His leadership and strategic planning were pivotal in achieving this notable success.